SHUTTLE PHARMACEUTICALS HOLDINGS, INC. Increase (Decrease) in Prepaid Expense and Other Assets
SHUTTLE PHARMACEUTICALS HOLDINGS, INC. (SHPH) reported Increase (Decrease) in Prepaid Expense and Other Assets of $137.21 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-09-24.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-09-24
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was -$1.07M.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was $1.20M, a 671.78% increase year-over-year.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was $797.02K.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-06-30 was -$72.55K.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month |
|---|---|---|---|
| 2026-06-30 | -$1.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-09-24 | $137.21K 10-Q · filed 2026-09-24 | |
| 2026-03-31 | $1.20M 10-Q · filed 2026-05-15 | ||
| 2025-09-30 | $797.02K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $724.48K derived: sum of 2 quarters · filed 2026-09-24 | $880.50K 10-Q · filed 2025-11-13 |
| 2025-06-30 | -$72.55K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-09-24 | $83.47K 10-Q · filed 2026-09-24 | |
| 2025-03-31 | $156.02K 10-Q · filed 2026-05-15 | ||
| 2024-09-30 | -$11.43K 10-Q · filed 2025-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |